Prostate-Specific Antigen Kinetics Following 5α-Reductase Inhibitor Treatment May Be a Useful Indicator for Repeat Prostate Biopsy

Ítems similars

• Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
  per: Lee, Kwang Suk, et al.
  Publicat: (2017)
• Is targeted biopsy really needed when performing systematic prostate biopsy to raise the detection rate for prostate cancer in patients with prostate-specific antigen ≤10 ng/mL?
  per: Park, Jee Soo, et al.
  Publicat: (2019)
• Comparison of prostate cancer detection rates of various prostate biopsy methods for patients with prostate-specific antigen levels of <10.0 ng/mL in real-world practice
  per: Oh, Kyung Tak, et al.
  Publicat: (2020)
• Clinical experience with active surveillance protocol using regular magnetic resonance imaging instead of regular repeat biopsy for monitoring: A study at a high-volume center in Korea
  per: Ahn, Hyun Kyu, et al.
  Publicat: (2021)
• The association of family history of prostate cancer with the diagnosis of clinically significant prostate cancer in Korean population
  per: Jee Soo Park, et al.
  Publicat: (2019-11-01)